IL6 and Sepsis: In the largest trial (97 evaluable patients), the use of haemoadsorption in patients with severe sepsis was not associated with any reduction in plasma IL-6 levels and had no effect on mortality once adjusting for comorbidities (hazard ratio 1.67, 95% CI 0.77 to 3.61) [48].